Compounds > 3,4-dihydroxyphenylacetic acid

3,4-dihydroxyphenylacetic acid and neuropeptide y, leu(31)-pro(34)-

3,4-dihydroxyphenylacetic acid has been researched along with neuropeptide y, leu(31)-pro(34)- in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hastings, JA; Morris, MJ; Pavia, JM1
Cheng, SM; Hsueh, YC; Pan, JT1

Other Studies

2 other study(ies) available for 3,4-dihydroxyphenylacetic acid and neuropeptide y, leu(31)-pro(34)-

ArticleYear
Neuropeptide Y and [Leu31,Pro34]neuropeptide Y potentiate potassium-induced noradrenaline release in the paraventricular nucleus of the aged rat.
    Brain research, 1997, Mar-07, Volume: 750, Issue:1-2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Cerebral Ventricles; Drug Synergism; Homovanillic Acid; Injections, Intraventricular; Male; Microdialysis; Neuropeptide Y; Norepinephrine; Paraventricular Hypothalamic Nucleus; Potassium; Rats; Rats, Sprague-Dawley; Time Factors

1997
Fasting stimulates tuberoinfundibular dopaminergic neuronal activity and inhibits prolactin secretion in oestrogen-primed ovariectomized rats: involvement of orexin A and neuropeptide Y.
    Journal of neuroendocrinology, 2002, Volume: 14, Issue:9

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Carrier Proteins; Dopamine; Estrogens; Fasting; Female; Intracellular Signaling Peptides and Proteins; Median Eminence; Neurons; Neuropeptide Y; Neuropeptides; Orexin Receptors; Orexins; Ovariectomy; Pituitary Gland, Posterior; Prolactin; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Receptors, Neuropeptide Y

2002